MSI Financial Services’s Ocular Therapeutix OCUL Stock Holding History

MSI Financial Services’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Buy	+500	New	+$3.88K	﹤0.01%	3245

Other funds holding OCUL

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

MSI Financial Services's OCUL Position: Q4 2016 in Review

MSI Financial Services opened a new position in Ocular Therapeutix (OCUL) in Q4 2016: 500 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #3245 among its holdings.

76 funds tracked by Wall St. Rank hold OCUL as of Q4 2016.

MSI Financial Services held 500 shares of Ocular Therapeutix worth $4K as of Q4 2016.
Ocular Therapeutix was a new MSI Financial Services position in Q4 2016.
Ocular Therapeutix made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3245 holding.
76 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.